Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

SGRY

BUY

Surgery Partners, Inc. · Healthcare · United States · $2.1B · Avg Vol: $20M/d

69
StockRank
Get insider-trade alerts
Q
43
V
60
M
59
P/E (TTM)
ROE
2.7%
D/E
1.2x
Dividend %

COMPANY DESCRIPTION

Surgery Partners, Inc. operates a comprehensive network of surgical facilities, encompassing ambulatory surgery centers (ASCs) and surgical hospitals, alongside ancillary services like urgent care centers and physician practices. The company focuses on delivering high-quality, cost-effective surgical care in outpatient settings. Surgery Partners is strategically positioned to capitalize on the ongoing shift of medical procedures from inpatient hospitals to more efficient outpatient facilities.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue2.5B2.7B3.1B3.3B9.2%3.3B3.4B3.6B4.1%
EPS-0.59-0.09-1.33-0.61-0.59
Shares126.0M126.6M127.1M129.3M+2.7%130.8M
Debt2.9B3.1B3.7B4.0B11.2%4.0B
Equity2.0B2.0B1.8B1.7B-5.0%
Op CF158.8M293.8M300.1M274.3M20.0%280.0M
Inv CF-307.9M-225.6M-488.5M-246.6M
Fin CF42.1M-155.2M262.0M-57.3M
Loading 1Y...
PRICE (1Y)+7.2%
14.2014.9615.7116.4717.23Jun 10Jul 2Jul 23
SMA 50SMA 200
Close
$15.22
RSI (14)
35.0
52W High
$24.10
From 52W High
0.6%

SCORE BREAKDOWN

Quality
43
ROIC
5.2%57.6
ROE
2.7%50.3
GP/Assets
9.4%24.7
Op. Margin
10.4%66.9
FCF/Assets
2.5%56.7
Piotroski
548.8
Int. Cover
1.4x40.2
D/E Ratio
1.16x12.2
Current Ratio
1.86x35.0
Value
60
P/E (TTM)
N/A
EV/EBITDA
11.8x60.7
P/FCF
10.3x81.6
P/B
1.2x78.2
P/S
0.6x89.6
Div Yield
N/A
Momentum
59
52W High %
63%43.7
RS 6M
-10%62.8
SMA 50/200
0.96x55.5
EPS Rev 4W
0.0%62.8
EPS Rev 12W
+68.5%98.3
EPS Improve
+211%88.5
Q Growth
N/A

FUNDAMENTALS

Market Cap
$2.1B
P/E (Forward)
24.5x
Gross Margin
22.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SGRY are excluded.

TickerCompanyMkt CapStockRankSignal
SGRYSurgery Partners, Inc.(you)$2.1B69BUY
PNTGThe Pennant Group, Inc.$1.4B64HOLD
INNVInnovAge Holding Corp.$1.6B76BUY
ACHCAcadia Healthcare Company, Inc.$3.2B73BUY
ASTHAstrana Health, Inc.$2.0B86STRONG BUY
OPCHOption Care Health, Inc.$3.4B60HOLD
LFSTLifeStance Health Group, Inc.$4.2B76BUY
GMRSGMR Solutions Inc.$701M71BUY
AVAHAveanna Healthcare Holdings Inc.$2.1B92STRONG BUY
ADUSAddus HomeCare Corporation$2.1B93STRONG BUY

Peer medians: ROE -21.2% · P/E 27.9x · Gross margin 50.0%

Surgery Partners, Inc. (SGRY) — Stock Score Summary

Surgery Partners, Inc. (SGRY) has a MoatMap StockRank of 69/100 based on Quality (43/100), Value (60/100), and Momentum (59/100) factor scores. The current signal is BUY.

Surgery Partners, Inc. operates a comprehensive network of surgical facilities, encompassing ambulatory surgery centers (ASCs) and surgical hospitals, alongside ancillary services like urgent care centers and physician practices. The company focuses on delivering high-quality, cost-effective surgical care in outpatient settings. Surgery Partners is strategically positioned to capitalize on the ongoing shift of medical procedures from inpatient hospitals to more efficient outpatient facilities.

Key Financial Metrics

Price$15.22
Market Cap$2.1B
P/E (Forward)24.50
Price/Book1.23
Return on Equity2.7%
Return on Invested Capital5.2%
Debt/Equity1.16x
Gross Margin22.8%
Operating Margin10.4%
Revenue Growth4.5%
Free Cash Flow$199M

Surgery Partners, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Surgery Partners, Inc.’s (SGRY) StockRank?
MoatMap’s StockRank for Surgery Partners, Inc. (SGRY) is 69/100, with a Buy signal. It is a composite of Quality (43), Value (60), and Momentum (59) factor ranks across MoatMap’s 20,000+ stock universe.
Does Surgery Partners, Inc. have an economic moat?
Surgery Partners, Inc. (SGRY) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Surgery Partners, Inc. a buy, hold, or sell?
MoatMap’s current signal for Surgery Partners, Inc. (SGRY) is Buy, based on a StockRank of 69/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Surgery Partners, Inc. in?
Surgery Partners, Inc. (SGRY) operates in the Healthcare sector, specifically the Medical Care Facilities industry (United States).